Clinical trials: Childhood and Adolescent Cancer
Brain and Central Nervous System Tumors, Neuroblastoma
Enzastaurin in Treating Young Patients With Refractory Primary CNS Tumors
RATIONALE: Enzastaurin may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.
- Trial name
- NCT00503724
- Testing
- enzastaurin hydrochloride
- Where
- 8 sites in United States
- Volunteers
- 32 people
- Sponsor
- Pediatric Brain Tumor Consortium
Childhood Cancer Survivor, Chronic Pain
Culturally Adapted Mobile Treatment of Chronic Pain in Adolescent Survivors of Pediatric Cancer: A Randomized Clinical Trial
The purpose of the study is to determine if an adapted mobile cognitive behavioral therapy (CBT) app (WebMAP Onc) is more effective than standard pain education in reducing chronic pain and improving daily functioning in…
- Trial name
- ADAPTED2 (NCT07160621)
- Testing
- Cognitive Behavioral Therapy (CBT), Education, Questionnaires
- Where
- United States
- Volunteers
- 116 people
- Sponsor
- St. Jude Children's Research Hospital
Nasopharyngeal Cancinoma (NPC)
GP Combined with Toripalimab Versus GP Induction Chemotherapy for Advanced Childhood Nasopharyngeal Carcinoma
Nasopharyngeal carcinoma (NPC) has a low incidence rate in children, accounting for only 1-2% of pediatric tumors. However, it is prone to metastasis, and most patients are already in advanced stages at the time of diagnosis.
- Trial name
- NCT06605131
- Testing
- GP+Toripalimab+CCRT, GP+CCRT
- Where
- China
- Volunteers
- 72 people
- Sponsor
- Sun Yat-sen University
Anaplastic Large Cell Lymphoma, Vinorelbine
Vinorelbine for Recurrent ACLC
The purpose of this study is to assess the efficiency and safety of vinorelbine in the treatment of relapsed / advanced ALCL in children and adolescents.
- Trial name
- NCT03397953
- Testing
- Vinorelbine
- Where
- China
- Volunteers
- 20 people
- Sponsor
- Children's Cancer Group, China
Childhood Cancer
Shanghai Epidemiology Study for Adolescents and Children With Cancer
The purpose of this study is to describe the morbidity, mortality, disability and survival rate in Shanghai adolescents and children with cancer diagnosed since January 2002.
- Trial name
- NCT02959086
- Where
- 2 sites in China
- Volunteers
- 2,000 people
- Sponsor
- Children's Cancer Group, China
Childhood Glioblastoma
Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGG
This phase I/II trials evaluates the feasibility, safety and efficacy of an individualized cancer vaccine, based on autologous, tumor-lysate loaded dendritic cells in children and adolescents with relapsed high-grade gliomas.
- Trial name
- NCT03879512
- Testing
- depletion of regulatory T cells, reoperation, cancer vaccine
- Where
- Germany
- Volunteers
- 24 people
- Sponsor
- Wuerzburg University Hospital
Childhood Cancer, Nausea with Vomiting Chemotherapy-Induced
Predict CHimio-or Radiation-induced NAusea and Vomiting in Children/adolescents Treated for Cancer
Chemo- or radiation-induced nausea and vomiting (CRVN) is one of the most frequent and feared side effects. It is a symptom that is few or not at all evaluated.
- Trial name
- PaNACHE (NCT06869005)
- Testing
- BARF scale
- Where
- 5 sites in France
- Volunteers
- 150 people
- Sponsor
- Rennes University Hospital
Sickle Cell Disease, Chronic Kidney Diseases
Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions
The purpose of this study is to test the efficacy of a peer support coaching intervention to improve activated chronic illness self-management versus an attention control group in 225 adolescents and young adults with childhood…
- Conditions
- Sickle Cell Disease, Chronic Kidney Diseases, Systemic Lupus Erythematosus, Childhood Cancer
- Trial name
- PiCASO (NCT03938324)
- Testing
- PiCASO Intervention Group
- Where
- United States
- Volunteers
- 222 people
- Sponsor
- Duke University
Leukemia
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
This study evaluates the safety and tolerability of combining venetoclax with Vyxeos (CPX-351) in pediatric and young adult patients with acute leukemia that has come back or not responded to treatment.
- Trial name
- NCT03826992
- Testing
- Vyxeos, Venetoclax
- Where
- United States
- Volunteers
- 21 people
- Sponsor
- Children's Hospital Medical Center, Cincinnati
Leukemia
Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia
RATIONALE: Studying samples of blood and bone marrow from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
- Trial name
- NCT01653613
- Testing
- DNA analysis, fluorescence in situ hybridization, gene expression analysis
- Volunteers
- 400 people
- Sponsor
- Eastern Cooperative Oncology Group
Primary/Relapsed Acute Lymphoblastic Leukemia (ALL) of Childhood, Adolescents and Young Adults
Patient-individualized Peptide Vaccination Based on Tumor-specific Mutations in Children and Young Adults With Primary/Relapsed ALL
The aim of this clinical study is to evaluate the feasibility and safety of an individualized peptide vaccination approach in patients with acute lymphoblastic leukemia (ALL).
- Trial name
- NCT03559413
- Testing
- Individual peptide vaccination with adjuvant GM-CSF and Imiquimod
- Where
- 5 sites in Germany
- Volunteers
- 30 people
- Sponsor
- University Children's Hospital Tuebingen
Hodgkin Lymphoma
Feasibility of High Intensity Interval Training in Survivors of Childhood, Adolescent, and Young Adult Hodgkin Lymphoma
This pilot study evaluates the feasibility of a 12-week high intensity interval training (HIIT) program in survivors of childhood, adolescent, and young adult Hodgkin lymphoma within 24 months of completing treatment.
- Trial name
- NCT07222345
- Testing
- High Intensity Interval Training (HIIT)
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- St. Jude Children's Research Hospital
Childhood Non-Hodgkin's Lymphoma
Improve the Survival Rate of Chinese Children and Adolescents With Non-Hodgkin's Lymphoma
Non-Hodgkin's lymphoma is an aggressive malignance disease in children and adolescents. This study was designed to evaluate the efficacy and toxicity of the modified NHL-BFM-90 protocol in Chinese children and adolescents with…
- Trial name
- NCT01761500
- Testing
- Modified BFM-90 protocol
- Volunteers
- 200 people
- Sponsor
- Sun Yat-sen University
Medulloblastoma, Childhood
Children's and Adolescents' Medulloblastoma Molecular Subgroups in China
Recently, diagnosis and treatments for medulloblastoma becomes more complicated than before since the new World Health Organization (WHO) diagnosis criteria has put molecular marker onto an ever important position.
- Trial name
- CNOG-MB001 (NCT03288168)
- Where
- 9 sites in China
- Volunteers
- 200 people
- Sponsor
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Unspecified Childhood Solid Tumor, Protocol Specific
AT9283 in Children and Adolescents With Relapsed and Refractory Solid Tumors
RATIONALE: AT9283 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase I trial is studying the side effects and best dose of AT9283 in children and adolescents with…
- Trial name
- NCT00985868
- Testing
- multikinase inhibitor AT9283, enzyme-linked immunosorbent assay, immunohistochemistry staining method
- Where
- 5 sites in United Kingdom
- Volunteers
- 33 people
- Sponsor
- Cancer Research UK
Lymphoblastic Leukemia, Acute, Childhood;
ALL-SCT BFM International- HSCT in Children and Adolescents With ALL
With this protocol the ALL-SCT BFM international study group wants to evaluate whether hematopoietic stem cell transplantation (HSCT) from matched family or unrelated donors (MD) is equivalent to the HSCT from matched sibling…
- Trial name
- ALL-SCT-BFMi (NCT01423500)
- Testing
- VP16, TBI, VP16, ATG
- Where
- 24 sites in Austria, Czechia and 9 more
- Volunteers
- 405 people
- Sponsor
- St. Anna Kinderkrebsforschung
Refractory or Recurrent Solid Tumors, Acute Myelogenous Leukemia
AZD2171 to Treat Children and Adolescents With Solid Tumors or Acute Myelogenous Leukemia
Background: AZD2171 is an experimental drug that may slow the growth of cancers by blocking angiogenesis (formation of new blood vessels). Cancer growth is dependent on angiogenesis for nutrition.
- Trial name
- NCT00321581
- Testing
- Cediranib, AZD2171, RECENTIN
- Where
- United States
- Volunteers
- 18 people
- Sponsor
- National Cancer Institute (NCI)
Supportive Care, Childhood Cancer
Home Chemotherapy Intervention for Children With Cancer - a Feasibility Study
Children with cancer undergo intensive treatment with many serious side effects and frequent in- and outpatient visits. Studies show that the frequent hospitalizations are very disruptive to children and their families, who…
- Trial name
- INTACTatHome (NCT05372536)
- Testing
- parent-led home-administered low-dose Cytarabine
- Where
- Denmark
- Volunteers
- 15 people, healthy volunteers welcome
- Sponsor
- Copenhagen University Hospital, Rigshospitalet
Unspecified Childhood Solid Tumor, Protocol Specific
Pemetrexed Disodium in Treating Young Patients With Recurrent Solid Tumors
RATIONALE: Drugs used in chemotherapy, such as pemetrexed disodium, use different ways to stop tumor cells from dividing so they stop growing or die.
- Trial name
- NCT00070473
- Testing
- pemetrexed disodium
- Where
- 20 sites in United States, Canada
- Volunteers
- 33 people
- Sponsor
- Children's Oncology Group
Lymphoblastic Leukemia, Acute, Childhood;
Allogeneic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia
With this protocol the ALL-SZT BFM international study group wants to evaluate whether hematopoietic stem cell transplantation (HSCT) from matched family or unrelated matched donors (MD) is equivalent to the HSCT from matched…
- Trial name
- NCT01423747
- Testing
- VP16, TBI, VP16, ATG
- Where
- 24 sites in Austria, Germany
- Volunteers
- 400 people
- Sponsor
- St. Anna Kinderkrebsforschung